What a SPAC-tacular year it has been in health tech investing! The allure of the public market was strong as we saw the highest number of health IPOs in years leaving many of us scratching our heads wondering what spurred this hot streak. What makes going public so appealing versus remaining under private investment? Debate the pros and cons with investment experts as we predict the future of SPACs and if regulatory bodies will cool the action.
